Pharmaceutical Technology

JUNE 29, 2022

In 2021, Novo Nordisk Pharmatech, a leading pharmaceutical-grade insulin and Quats product supplier announced plans to enter the enzyme market. By building upon its core competency, Novo Nordisk Pharmatech will begin serving the emerging regenerative medicine and advanced therapy markets through best-in-class speciality enzymes.

Drugs 295

Drugs Gene Therapy Manufacturing Production 295

The Pharma Data

NOVEMBER 4, 2020

With years of extensive experience in the field of skin health, the Company has successively built the “Juyou” brand for skin barrier repair, now recommended by thousands of public hospitals in China ; the professional baby skincare brand “Juyou Baby”, as well as the “Dermacid” brand, just to name a few.

Licensing 40

Licensing Licensing Dermatology Production 40

The Pharma Data

OCTOBER 27, 2020

The decrease in Adcirca revenues was driven by continued erosion of market share due to generic competition. Sales and marketing. Cash, cash equivalents, and marketable investments. Cost of product sales. Dollar Change. .

Production 40

Production Sales Licensing Licensing 40